Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

15.89
Delayed Data
As of Jun 29
 +0.41 / +2.65%
Today’s Change
14.07
Today|||52-Week Range
18.04
-1.91%
Year-to-Date
No recent news for Grifols SA.

Today’s Trading

Previous close15.48
Today’s open16.13
Day’s range15.83 - 16.20
Volume611,420
Average volume (3 months)1,383,584
Market cap$4.0B
Dividend yield2.23%
Data as of 06/29/2016

Growth & Valuation

Earnings growth (last year)-5.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.80%
Revenue growth (last year)-2.06%
P/E ratio--
Price/Sales2.56
Price/Book2.95

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+1.51+3.44%
ICPTIntercept Pharmaceut...+0.50+0.33%
ENDPEndo International P...-0.26-1.61%
ACADACADIA Pharmaceutica...+0.72+2.27%
Data as of 06/29/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.26
Annual revenue (last year)$4.3B
Annual profit (last year)$587.3M
Net profit margin13.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Víctor Grifols Roura
Chief Financial Officer &
Vice President
Alfredo Arroyo Guerra
Corporate headquarters
Barcelona, Catalonia

Forecasts

Partner Offers

Search for Jobs